FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2531438029> ?p ?o ?g. }

• W2531438029 endingPage "588" @default.
• W2531438029 startingPage "581" @default.
• W2531438029 abstract "To evaluate the utility of a standardized qualitative scoring system for treatment response assessment at 18F-FDG PET-CT in patients undergoing chemoradiotherapy for locally advanced cervical carcinoma and correlate this with subsequent patient outcome. Ninety-six consecutive patients with locally advanced cervical carcinoma treated with radical chemoradiotherapy (CRT) in a single centre between 2011 and 2014 underwent 18F-FDG PET-CT approximately 3 months post-treatment. Tumour metabolic response was assessed qualitatively using a 5-point scale ranging from background level activity only through to progressive metabolic disease. Clinical and radiological (MRI pelvis) follow-up was performed in all patients. Progression-free (PFS) and overall survival (OS) was calculated using the Kaplan-Meier method (Mantel-Cox log-rank) and correlated with qualitative score using Chi-squared test. Forty patients (41.7 %) demonstrated complete metabolic response (CMR) on post-treatment PET-CT (Score 1/2) with 38 patients (95.0 %) remaining disease free after a minimum follow-up period of 18 months. Twenty-four patients (25.0 %) had indeterminate residual uptake (ID, Score 3) at primary or nodal sites after treatment, of these eight patients (33.3 %) relapsed on follow-up, including all patients with residual nodal uptake (n = 4Eleven11 of 17 patients (64.7 %) with significant residual uptake (partial metabolic response, PMR, Score 4) subsequently relapsed. In 15 patients (15.6 %) PET-CT demonstrated progressive disease (PD, Score 5) following treatment. Kaplan-Meier analysis showed a highly statistically significant difference in PFS and OS between patients with CMR, indeterminate uptake, PMR and PD (Log-rank, P < 0.0001). Chi-squared test demonstrated a highly statistically significant association between increasing qualitative score and risk of recurrence or death (P < 0.001). Use of a 5-point qualitative scoring system to assess metabolic response to CRT in locally advanced cervical carcinoma predicts survival outcome and this prognostic information may help guide further patient management." @default.
• W2531438029 created "2016-10-21" @default.
• W2531438029 creator A5009197248 @default.
• W2531438029 creator A5013507493 @default.
• W2531438029 creator A5019234590 @default.
• W2531438029 creator A5055130925 @default.
• W2531438029 creator A5076054268 @default.
• W2531438029 creator A5083669414 @default.
• W2531438029 date "2016-10-14" @default.
• W2531438029 modified "2023-10-07" @default.
• W2531438029 title "Efficacy of qualitative response assessment interpretation criteria at 18F-FDG PET-CT for predicting outcome in locally advanced cervical carcinoma treated with chemoradiotherapy" @default.
• W2531438029 cites W1542150947 @default.
• W2531438029 cites W1928624976 @default.
• W2531438029 cites W1966185473 @default.
• W2531438029 cites W1969621903 @default.
• W2531438029 cites W1972062490 @default.
• W2531438029 cites W2008790806 @default.
• W2531438029 cites W2073419672 @default.
• W2531438029 cites W2076075334 @default.
• W2531438029 cites W2076939347 @default.
• W2531438029 cites W2080461388 @default.
• W2531438029 cites W2081662013 @default.
• W2531438029 cites W2093777090 @default.
• W2531438029 cites W2094983511 @default.
• W2531438029 cites W2097945491 @default.
• W2531438029 cites W2112855745 @default.
• W2531438029 cites W2120405223 @default.
• W2531438029 cites W2124831076 @default.
• W2531438029 cites W2131900456 @default.
• W2531438029 cites W2145034052 @default.
• W2531438029 cites W2145246933 @default.
• W2531438029 cites W2153355186 @default.
• W2531438029 cites W2257423691 @default.
• W2531438029 cites W2276128359 @default.
• W2531438029 cites W2336390599 @default.
• W2531438029 cites W2464450022 @default.
• W2531438029 cites W887223673 @default.
• W2531438029 cites W934026702 @default.
• W2531438029 doi "https://doi.org/10.1007/s00259-016-3537-8" @default.
• W2531438029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5323466" @default.
• W2531438029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27738729" @default.
• W2531438029 hasPublicationYear "2016" @default.
• W2531438029 type Work @default.
• W2531438029 sameAs 2531438029 @default.
• W2531438029 citedByCount "20" @default.
• W2531438029 countsByYear W25314380292017 @default.
• W2531438029 countsByYear W25314380292018 @default.
• W2531438029 countsByYear W25314380292019 @default.
• W2531438029 countsByYear W25314380292020 @default.
• W2531438029 countsByYear W25314380292021 @default.
• W2531438029 countsByYear W25314380292022 @default.
• W2531438029 countsByYear W25314380292023 @default.
• W2531438029 crossrefType "journal-article" @default.
• W2531438029 hasAuthorship W2531438029A5009197248 @default.
• W2531438029 hasAuthorship W2531438029A5013507493 @default.
• W2531438029 hasAuthorship W2531438029A5019234590 @default.
• W2531438029 hasAuthorship W2531438029A5055130925 @default.
• W2531438029 hasAuthorship W2531438029A5076054268 @default.
• W2531438029 hasAuthorship W2531438029A5083669414 @default.
• W2531438029 hasBestOaLocation W25314380291 @default.
• W2531438029 hasConcept C10515644 @default.
• W2531438029 hasConcept C126322002 @default.
• W2531438029 hasConcept C126838900 @default.
• W2531438029 hasConcept C127077266 @default.
• W2531438029 hasConcept C2775842073 @default.
• W2531438029 hasConcept C2778424827 @default.
• W2531438029 hasConcept C2778822529 @default.
• W2531438029 hasConcept C2779134260 @default.
• W2531438029 hasConcept C2989005 @default.
• W2531438029 hasConcept C50382708 @default.
• W2531438029 hasConcept C509974204 @default.
• W2531438029 hasConcept C66339696 @default.
• W2531438029 hasConcept C71924100 @default.
• W2531438029 hasConceptScore W2531438029C10515644 @default.
• W2531438029 hasConceptScore W2531438029C126322002 @default.
• W2531438029 hasConceptScore W2531438029C126838900 @default.
• W2531438029 hasConceptScore W2531438029C127077266 @default.
• W2531438029 hasConceptScore W2531438029C2775842073 @default.
• W2531438029 hasConceptScore W2531438029C2778424827 @default.
• W2531438029 hasConceptScore W2531438029C2778822529 @default.
• W2531438029 hasConceptScore W2531438029C2779134260 @default.
• W2531438029 hasConceptScore W2531438029C2989005 @default.
• W2531438029 hasConceptScore W2531438029C50382708 @default.
• W2531438029 hasConceptScore W2531438029C509974204 @default.
• W2531438029 hasConceptScore W2531438029C66339696 @default.
• W2531438029 hasConceptScore W2531438029C71924100 @default.
• W2531438029 hasFunder F4320320298 @default.
• W2531438029 hasIssue "4" @default.
• W2531438029 hasLocation W25314380291 @default.
• W2531438029 hasLocation W25314380292 @default.
• W2531438029 hasLocation W25314380293 @default.
• W2531438029 hasLocation W25314380294 @default.
• W2531438029 hasOpenAccess W2531438029 @default.
• W2531438029 hasPrimaryLocation W25314380291 @default.
• W2531438029 hasRelatedWork W1593574816 @default.
• W2531438029 hasRelatedWork W19333003 @default.
• W2531438029 hasRelatedWork W2415876953 @default.
• W2531438029 hasRelatedWork W2464905242 @default.

• next